Feed / ATAI

AtaiBeckley Inc.

ATAI

Healthcare · 7.35 +0.7% today

Isolated · not yet confirmedMarket checked 10 Sept, 15:55 GMT-4

Market read

AtaiBeckley Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 7 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.

Company+0.7% todayVolume comparison unavailable
Market group0 of 7 activeGovernment Services & Retail · unavailable
Disclosed network0 of 2 confirmingNo filing-linked name is confirming now
What would change this read
  • ATAI's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if ATAI's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Healthcare · Biotechnology

No new filing conclusion is available. 0 of 7 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • ATAI's market-adjusted activity becomes unusual and at least one connected name confirms.

Company research

Understand the business, not just the ticker

As of Sep 11, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods2
Price observations319
Usable filing statements50
Verified relationships3
Evidence supporting the case
  • Latest annual revenue changed +1227.6% year over year.
  • Operating margin changed +17590.2 percentage points in the latest annual period.
  • Net margin changed +32321.9 percentage points in the latest annual period.
Evidence challenging the case
  • Diluted shares increased 41.4% in the latest annual period.
Questions before a position
  • EV/sales is 2516% above the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context

Price as of Sep 10, 2026

7.35
6m+102.5%12m+60.8%24m
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2024-12-31$308,000$-0.93
2025-12-31$4.1M+1227.6%$-2.91+41.4%

What management says matters

Persistent and emerging business drivers

Foreign exchangemixed · 1 filings
These losses were partially offset by a $0.5 million non-cash gain related to unrealized foreign exchange revaluation.
10-Q · May 12, 2026
Product pipeline and R&Dnegative · 1 filings
Discovery The $0.1 million net decrease in discovery costs was primarily due to a $0.6 million reduction in our research and development expenses related to our discovery program as certain expenses qualified for reimbursement under our National Health Instit…
10-Q · May 12, 2026
Restructuring and cost reductionsnegative · 1 filings
Other Programs The $2.7 million decrease in direct costs for our other programs was primarily due to a $1.9 million decrease in direct costs for our RL-007 program as a result of a decrease in clinical development and related costs for our Phase 2b clinical t…
10-Q · May 12, 2026
Supply chain and availabilitynegative · 1 filings
Adjustments resulting from translating foreign functional currency financial statements into U.S.
10-Q · May 12, 2026

Valuation discipline

Descriptive valuation snapshot

Price/sales 407.2× · EV/sales 386.3×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Fewer than 4 annual revenue periods; too little history to scaffold scenarios.

Price action

How the market is pricing the story

7.35+0.7% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 10 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for ATAI. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for ATAI. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind ATAI

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

HTGCHercules Capital, Inc.lenderMay 12, 2026

Term Loan Hercules Loan and Security Agreement In August 2022, the Company and certain subsidiaries, as guarantors, and Hercules Capital, Inc., a Maryland corporation (“Hercules”), entered into a Loan and Security Agreement (as amended, the “Hercules Loan Agr…

Depended on by

DFTXDefinium Therapeutics, Inc.competitorFeb 26, 2026

A number of companies are developing product candidates with similar mechanisms to DT120 that are intended for the treatment of anxiety and depressive disorders, including AtaiBeckley Inc.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 2 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

ATAI is currently a Early Follower in the organic co-movement group Government Services & Retail. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for ATAI; it is not active in the latest market snapshot.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.